Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lahlou

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Human Reproduction (Oxford, England)|May 15, 1999
Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?N Lahlou, N Chabbert-Buffet, S Christin-Maitre, et al.
Fertility and Sterility|February 1, 1996
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadismB Mannaerts, B Fauser, N Lahlou, et al.
Obesity Research|July 1, 1994
Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese womenB Laferrère, N Lahlou, H Saltiel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormoneP Bougnères, M François, L Pantalone, et al.
Journal of Endocrinological Investigation|February 1, 1994
Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomasP Chanson, N Lahlou, A Warnet, et al.
Clinical Endocrinology|March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in menN Lahlou, E Le Nestour, P Chanson, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|May 1, 1990
[Prognostic factors in delivery with breech presentation. Apropos of 357 single-fetus pregnancies at term]L Rosenau, P Grosieux, A Denis, et al.
Diabetes|May 20, 1998
Overexpression of placental leptin in diabetic pregnancy: a critical role for insulinJ Lepercq, M Cauzac, N Lahlou, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious PubertyJ C Carel, M Roger, S Ispas, et al.
American Journal of Obstetrics and Gynecology|March 1, 1996
Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiolR A Rey, C Lhommé, I Marcillac, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Human Reproduction (Oxford, England)|May 15, 1999
Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?N Lahlou, N Chabbert-Buffet, S Christin-Maitre, et al.
Fertility and Sterility|February 1, 1996
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadismB Mannaerts, B Fauser, N Lahlou, et al.
Obesity Research|July 1, 1994
Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese womenB Laferrère, N Lahlou, H Saltiel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormoneP Bougnères, M François, L Pantalone, et al.
Journal of Endocrinological Investigation|February 1, 1994
Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomasP Chanson, N Lahlou, A Warnet, et al.
Clinical Endocrinology|March 1, 1993
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in menN Lahlou, E Le Nestour, P Chanson, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|May 1, 1990
[Prognostic factors in delivery with breech presentation. Apropos of 357 single-fetus pregnancies at term]L Rosenau, P Grosieux, A Denis, et al.
Diabetes|May 20, 1998
Overexpression of placental leptin in diabetic pregnancy: a critical role for insulinJ Lepercq, M Cauzac, N Lahlou, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious PubertyJ C Carel, M Roger, S Ispas, et al.
American Journal of Obstetrics and Gynecology|March 1, 1996
Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiolR A Rey, C Lhommé, I Marcillac, et al.
Pageof 8